- - Welcome!
- - What do we do as more studies come out?
- - From early RCT: robust inference of Remdesivir effect on time to clinical improvement
- - A 15-min talk
- - From early RCT: effect of Remdesivir on mortality could go either way
- - First example: Pneumonia finding from initial hydroxychloroquine RCT only requires 1 ‘switch’ to invalidate
- - Why is robustness important for emerging COVID-19 studies?